SB 164

  • Oklahoma Senate Bill
  • 2021 Regular Session
  • Introduced in Senate Mar 03, 2021
  • Passed Senate Mar 02, 2021
  • Passed House Apr 21, 2021
  • Signed by Governor Apr 27, 2021

Medical care; modifying provisions related to informed consent to experimental treatment. Effective date.

Votes


No votes to display

Actions


Apr 27, 2021

Senate

Approved by Governor 04/27/2021

Apr 22, 2021

Senate

Sent to Governor

House

Signed, returned to Senate

Senate

Enrolled, to House

Apr 21, 2021

House

Coauthored by Representative(s) Pittman

House

General Order

Senate

Referred for enrollment

House

Signed, returned to Senate

House

Third Reading, Measure passed: Ayes: 80 Nays: 13

Mar 31, 2021

House

CR; Do Pass Public Health Committee

Mar 22, 2021

House

Second Reading referred to Public Health

Mar 03, 2021

House

First Reading

Senate

Engrossed to House

Mar 02, 2021

Senate

Referred for engrossment

Senate

Measure passed: Ayes: 43 Nays: 2

Senate

General Order, Considered

Feb 24, 2021

Senate

Coauthored by Representative Roe (principal House author)

Feb 03, 2021

Senate

Reported Do Pass Health and Human Services committee; CR filed

Feb 02, 2021

Senate

Second Reading referred to Health and Human Services

Feb 01, 2021

Senate

Authored by Senator Stanley

Senate

First Reading

Bill Text

Bill Text Versions Format
Introduced PDF
Floor (House) PDF
Floor (Senate) PDF
Engrossed PDF
Enrolled (final version) PDF

Related Documents

Document Format
Senate Committee Report PDF
House Committee Report PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Oklahoma Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.